Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock OXFORD IMMUNOTEC LIMITED's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteOXFORD IMMUNOTEC LIMITED
143 PARK DRIVE, MILTON, ABINGDON, OX14 4SE
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
OXFORD IMMUNOTEC LIMITED
Private limited with Share Capital
Active - Accounts Filed
21 August 2002
21200 Manufacture of pharmaceutical preparations - Manufacture of pharmaceutical preparations
Available to 24 Dec 2025. Next accounts due by 30 Sep 2026
Is OXFORD IMMUNOTEC LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mr Anthony Paul Eastoe | Director | ||
| Mrs Jemma Parsons | Director | ||
| Mr Steven Christopher Hart | Director | ||
| Mr John Leo Healy | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
0
Total Satisfied
15
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Barclays Bank PLC | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Midcap Financial Trust (As Security Agent) | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Midcap Financial Trust (As Security Agent) | SATISFIED | |||
| Midcap Financial Trust (As Agent) | SATISFIED | |||
| Square 1 Bank | SATISFIED | |||
| Third Party Security Agreement | Comerica Bank | SATISFIED | ||
| Debenture | Comerica Bank | SATISFIED | ||
| Debenture | Prelude Trust PLC (The Security Trustee) | SATISFIED | ||
| Debenture | Prelude Trust PLC (The Security Trustee) | SATISFIED | ||
| Debenture | Prelude Trust PLC As Security Trustee For The Noteholders | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £7,045,000.00 | £7,370,000.00 | £3,588,000.00 | £3,588,000.00 | £4,924,000.00 |
| Net Worth | -£38,836,000.00 | -£32,949,000.00 | -£6,719,000.00 | -£6,719,000.00 | £4,142,000.00 |
| Total Current Liabilities | £78,987,000.00 | £73,367,000.00 | £74,221,000.00 | £74,221,000.00 | £66,150,000.00 |
| Total Current Assets | £29,106,000.00 | £26,997,000.00 | £29,431,000.00 | £29,431,000.00 | £26,240,000.00 |
Frequently Asked Questions about OXFORD IMMUNOTEC LIMITED
Detailed answers about OXFORD IMMUNOTEC LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD IMMUNOTEC LIMITED founded?
OXFORD IMMUNOTEC LIMITED was officially incorporated on 21 August 2002 and is registered under company number 04516079. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD IMMUNOTEC LIMITED?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD IMMUNOTEC LIMITED?
OXFORD IMMUNOTEC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD IMMUNOTEC LIMITED do?
OXFORD IMMUNOTEC LIMITED operates in the following sector: 21200 Manufacture of pharmaceutical preparations - Manufacture of pharmaceutical preparations . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is OXFORD IMMUNOTEC LIMITED's registered address?
The registered office address of OXFORD IMMUNOTEC LIMITED is 143, Park Drive Drive, Abingdon, Oxfordshire, OX14 4SE. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD IMMUNOTEC LIMITED financially stable?
Based on the latest accounts up to 24 Dec 2025, OXFORD IMMUNOTEC LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.